AHA/ASA releases new guideline on prevention of secondary stroke
USA: The American Heart Association/American Stroke Association has released a 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack.According to the guideline, when possible, diagnostic tests to determine the cause of a first stroke or transient ischemic attack (TIA) should be completed within 48 hours after symptom onset.The guideline, published...
USA: The American Heart Association/American Stroke Association has released a 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack.
According to the guideline, when possible, diagnostic tests to determine the cause of a first stroke or transient ischemic attack (TIA) should be completed within 48 hours after symptom onset.
The guideline, published in the AHA journal Stroke, provides clinicians with evidence-based recommendations for the prevention of future stroke among survivors of ischemic stroke or Transient Ischemic Attack.
The guideline includes a section outlining treatment recommendations based on the cause of the initial stroke/TIA. Underlying causes could be related to blockages in large arteries in the neck or brain, small arteries in the brain-damaged from high blood pressure or diabetes, irregular heart rhythms and many other potential causes.
"It is critically important to understand the best ways to prevent another stroke once someone has had a stroke or a TIA," said Dawn O. Kleindorfer, M.D., FAHA, chair of the guideline writing group, and professor and chair of the department of neurology at the University of Michigan School of Medicine in Ann Arbor, Michigan. "If we can pinpoint the cause of the first stroke or TIA, we can tailor strategies to prevent a second stroke."
For patients who have survived a stroke or TIA, the secondary prevention guidelines recommend:
Managing their vascular risk factors, especially high blood pressure, as well as Type 2 diabetes, cholesterol, triglyceride levels and not smoking.
Limiting salt intake and/or following a Mediterranean diet.
If they are capable of physical activity, engaging in moderate-intensity aerobic activity for at least 10 minutes four times a week or vigorous-intensity aerobic activity for at least 20 minutes twice a week.
"In fact, approximately 80% of strokes can be prevented by controlling blood pressure, eating a healthy diet, engaging in regular physical activity, not smoking and maintaining a healthy weight," said Amytis Towfighi, M.D., FAHA, vice-chair of the guideline writing group, and director of neurological services at the Los Angeles County Department of Health Services.
For health care professionals, the updated treatment recommendations highlighted in the guideline include:
Using multidisciplinary care teams to personalize care for patients and employing shared decision-making with the patient to develop care plans that incorporate a patient's wishes, goals and concerns.
Screening for and diagnosing atrial fibrillation (an irregular heart rhythm) and starting blood-thinning medications to reduce recurrent events.
Prescribing antithrombotic therapy, including antiplatelet medications (blood thinners) or anticoagulant medications (to prevent blood clotting), for nearly all patients who don't have contraindications. However, the combination of antiplatelets and anticoagulation is typically not recommended for preventing second strokes, and dual antiplatelet therapy, taking aspirin along with a second medicine to prevent blood clotting, is recommended short-term, only for specific patients: those with early arriving minor stroke and high-risk TIA or severe symptomatic stenosis.
Carotid endarterectomy, surgical removal of a blockage or, in select cases, the use of a stent in the carotid artery, should be considered for patients with narrowing arteries in the neck.
Aggressive medical management of risk factors and short-term dual anti-platelet therapy are preferred for patients with severe intracranial stenosis thought to cause the stroke or TIA.
In some patients, it is now reasonable to consider percutaneously closing (a less invasive, catheter-based surgical procedure) a patent foramen ovale, a small and fairly common heart defect.
The guideline is accompanied by a systematic review article, published simultaneously, "Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention." The review paper, chaired, by Devin L. Brown, M.D., M.S., is a meta-analysis of three short-duration clinical trials on dual antiplatelet therapy (DAPT) and concludes DAPT may be appropriate for select patients.
The review authors note: "Additional research is needed to determine: the optimal timing of starting treatment relative to the clinical event; the optimal duration of DAPT to maximize the risk-benefit ratio; whether additional populations excluded from POINT and CHANCE [two of the trials examined], such as those with major stroke, may also benefit from early DAPT; and whether certain genetic profiles eliminate the benefit of early DAPT."
"The secondary prevention of stroke guideline is one of the American Stroke Association's 'flagship' guidelines, last updated in 2014," Kleindorfer added. "There are also a number of changes to the writing and formatting of this guideline to make it easier for professionals to understand and locate information more quickly, ultimately greatly improving patient care and preventing more strokes in our patients."
Having a stroke caused by blocked blood vessels or a transient ischemic attack greatly increases the chances of having a future stroke. Identifying the cause or causes of the first stroke is key to developing strategies to prevent additional strokes. Managing blood pressure levels, reducing or quitting smoking, eating a healthy diet, and regular physical activity will reduce the risk of a second stroke, along with managing conditions such as Type 2 diabetes and high cholesterol.
"2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association," is published in the AHA journal Stroke.
Medha, MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at email@example.com. Contact no. 011-43720751